🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Joseph Azar

The Ohio State University

ORCID: 0000-0001-9518-2908

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Phase I Trial Characterizing the Pharmacokinetic Profile of N-803, a Chimeric IL-15 Superagonist, in Healthy Volunteers”.

Phase I Trial Characterizing the Pharmacokinetic Profile of N-803, a Chimeric IL-15 Superagonist, in Healthy Volunteers

The Journal of Immunology(2022)10.4049/jimmunol.2100066

N/A

0DataRank · unranked

22 citations

Cameron E. Williams, Caroline Mart, Jonathan Beall, Linda MacPherson, Joseph Azar +12 more

Selective suppression of de novo SARS-CoV-2 vaccine antibody responses in patients with cancer on B cell–targeted therapy

JCI Insight(2023)10.1172/jci.insight.163434

N/A

0DataRank · unranked

4 citations

John P. Evans, Madison Sikorski, Karthik B. Chakravarthy, Selah McKenney, Ian Carmody +24 more

Translational and oncologic significance of tertiary lymphoid structures in pancreatic adenocarcinoma

Frontiers in Immunology(2024)10.3389/fimmu.2024.1324093

N/A

0DataRank · unranked

4 citations

Joseph Azar, Huili Zhu, Sophia Williams‐Perez, Sung Wook Kang, Celia Marginean +5 more